(1) Regulation 20(2)(a) of the principal regulations is amended by adding the words “, subject to subclause (3)”.
“, subject to subclause (3)”
(2) Regulation 20 of the principal regulations is amended by adding the following subclause:
“(3) For the purposes of subclause (2)(a), the following restrictions apply to the supply of any preparation of pseudoephedrine described in paragraph (b) of the definition of partially exempted drug:“(a) the preparation may be sold by retail, or supplied in circumstances corresponding to retail sale, only in the circumstances set out in paragraphs (a) and (b) of the definition of pharmacy-only medicine in section 3 of the Medicines Act 1981; and“(b) the package in which the preparation is sold or supplied must not contain more than 1.8 g of pseudoephedrine.”
“(3) For the purposes of subclause (2)(a), the following restrictions apply to the supply of any preparation of pseudoephedrine described in paragraph (b) of the definition of partially exempted drug:
“(a) the preparation may be sold by retail, or supplied in circumstances corresponding to retail sale, only in the circumstances set out in paragraphs (a) and (b) of the definition of pharmacy-only medicine in section 3 of the Medicines Act 1981; and
“(b) the package in which the preparation is sold or supplied must not contain more than 1.8 g of pseudoephedrine.”